
    
      All subjects will receive daily oral dosing of peanut OIT (oral immunotherapy) in the form of
      Characterized Peanut Allergen (CPNA).

      Study Duration - 12-90 weeks before reaching the Extended Maintenance Phase. All Subjects may
      continue Extended Maintenance Phase until CPNA becomes commercially available or the study is
      terminated.
    
  